Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric Cancer-Reference-Cited by-同舟云学术

Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric Cancer

Published:2014-03-07 Issue:7 Volume:21 Page:2340-2346
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Oki Eiji,Emi Yasunori,Kusumoto Tetsuya,Sakaguchi Yoshihisa,Yamamoto Manabu,Sadanaga Noriaki,Shimokawa Mototsugu,Yamanaka Takeharu,Saeki Hiroshi,Morita Masaru,Takahashi Ikuo,Hirabayashi Naoki,Sakai Kenji,Orita Hiroyuki,Aishima Shinichi,Kakeji Yoshihiro,Yamaguchi Kazuya,Yoshida Kazuhiro,Baba Hideo,Maehara Yoshihiko

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-014-3594-9.pdf

Reference25 articles.

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29.

2. Yoshikawa T, Sasako M. Gastrointestinal cancer: adjuvant chemotherapy after D2 gastrectomy for gastric cancer. Nat Rev Clin Oncol. 2012;9:192–94.

3. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.

4. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453–62.

5. Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29:4387–93.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial;Nature Communications;2024-01-02

2. Effects of Clavien-Dindo Classification on Long-Term Survival of Patients With Advanced Gastric Cancer After Radical Resection: A Propensity Score-matched Study;The American Surgeon™;2023-09-07

3. Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients;International Journal of Clinical Oncology;2023-06-27

4. Phase II Clinical Trial to Study the Safety and Efficacy of Combined S-1 + Oxaliplatin Therapy as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer in Older Patients;2023-05-08

5. Editorial: Surgical interventions in gastric cancer;Frontiers in Oncology;2022-08-16